Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 3Completed 2Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 9OTHER 2NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1Arthritis, Rheumatoid 1

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 330Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 281Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER × tofacitinib × Clear all
NCT04431895 2025-09-16

Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

Huashan Hospital

Phase EARLY_PHASE1 Completed
19 enrolled

Myasthenia Gravis

NCT04798287 2022-06-22

STAR-RA-Cancer

Brigham and Women's Hospital

Completed
105,711 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡